Kelly William John

SEC source: 0001213900-24-112330 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,241

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $11.65 to $12.56 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-105583 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,260

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.66 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-100909 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,478

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $8.91 to $9.12 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-081025 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,587

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.62 to $6.03 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-076173 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,624

F2 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2021.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $5.56 to $6.27 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071364 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,893

F2 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $6.16 to $6.51 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071364 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,986

F1 · kind: Represents restricted stock units ("RSUs") transferred to the reporting person's ex-spouse pursuant to a divorce decree. The RSUs owned by the ex-spouse are not beneficially owned by the reporting person.

SEC source: 0001013762-24-000388 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,798

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · derivative · entry 4

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,735

Underlying: Common Stock · 3,472 shares

Expires 2031-11-22

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

F6 · derivative.exercise_date: The shares underling this option vest subject to the reporting person's continued service as follows: 218 vested on December 20, 2021, with the remainder vesting in equal monthly installments over the following 36-month period.

F5 · derivative.underlying_shares: On June 12, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The figures reported have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · derivative · entry 3

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,071

Underlying: Common Stock · 34,143 shares

Expires 2031-02-24

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

F4 · derivative.exercise_date: The shares underlying this option vest subject to the reporting person's continued service as follows :8,538 vested on January 29, 2022, with the remainder vesting in equal monthly installments over the following 36-month period.

F5 · derivative.underlying_shares: On June 12, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The figures reported have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,810

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

SEC source: 0001213900-24-053880 · ownership.xml · derivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,162

Underlying: Class A Common Stock · 12,162 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Kelly's continued service through the applicable vesting date.

SEC source: 0001213900-24-049598 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 504,767

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-045509 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 511,295

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3799 to $0.3920 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-024749 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 517,841

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.321 to $0.3511 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-020148 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 519,131

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.357 to $0.38 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-015860 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 526,666

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.35 to $0.3772 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-084709 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 534,221

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.4199 to $0.4713 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001013762-23-002456 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 539,205

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.4779 to $0.4951 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-078780 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544,063

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7701 to $0.80 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075087 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 545,170

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F4 · price: This figure is the weighted average sales price of multiple trades ranging from $0.961 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075087 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,050

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9481 to $0.9915 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-069798 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 556,511

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.8881 to $0.9508 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-064919 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 562,989

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.8332 to $0.9548 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-055122 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 567,974

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.78 to $1.875 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-051008 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,833

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.06 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-046722 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 573,939

F2 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $2.12 to $2.225 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-046722 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 578,808

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-042680 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,759

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.090 to $2.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-037359 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,238

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.11 to $2.24 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-028189 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,277

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

SEC source: 0001213900-23-022510 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,188

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-23-018397 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,327

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.64 to $2.76 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-013745 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,281

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $2.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-009200 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,568

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.91 to $3.15 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-001343 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,704

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.91 to $2.09 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-082170 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,709

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.795 to $1.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-077968 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,782

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.92 to $3.31 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-074683 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,067

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.13 to $3.405 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-070676 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,136

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.65 to $3.935 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065176 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,760

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.335 to $3.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065176 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,760

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.38 to $3.65 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-058108 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,384

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4 filed on September 7, 2022 reflected an error.

SEC source: 0001213900-22-054627 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,374

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053919 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,505

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053919 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,944

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.685 to $3.81 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052741 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,414

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.73 to $3.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052741 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,793

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $3.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-051793 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,160

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.94 to $4.17 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-051793 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,901

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.905 to $4.26 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.